Major trial tests new drug combo in fight against advanced lung cancer

NCT ID NCT00532155

Completed Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This large, completed study tested whether adding the drug aflibercept to standard chemotherapy (docetaxel) helped people with advanced non-small cell lung cancer live longer. It involved over 900 participants whose cancer had worsened after one prior platinum-based treatment. The main goal was to see if the new combination improved overall survival compared to chemotherapy alone.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Sanofi-Aventis Administraive Office

Istanbul, Turkey (Türkiye)
Sanofi-Aventis Administrative Office

Bridgewater, New Jersey, 08807, United States
Sanofi-Aventis Administrative Office

Buenos Aires, Argentina
Sanofi-Aventis Administrative Office

Vienna, Austria
Sanofi-Aventis Administrative Office

São Paulo, Brazil
Sanofi-Aventis Administrative Office

Sofia, Bulgaria
Sanofi-Aventis Administrative Office

Laval, Canada
Sanofi-Aventis Administrative Office

Santiago, Chile
Sanofi-Aventis Administrative Office

Shanghai, China
Sanofi-Aventis Administrative Office

Prague, Czechia
Sanofi-Aventis Administrative Office

Tallinn, Estonia
Sanofi-Aventis Administrative Office

Helsinki, Finland
Sanofi-Aventis Administrative Office

Paris, France
Sanofi-Aventis Administrative Office

Berlin, Germany
Sanofi-Aventis Administrative Office

Athens, Greece
Sanofi-Aventis Administrative Office

Causeway Bay, Hong Kong
Sanofi-Aventis Administrative Office

Budapest, Hungary
Sanofi-Aventis Administrative Office

Mumbai, India
Sanofi-Aventis Administrative Office

Milan, Italy
Sanofi-Aventis Administrative Office

Kuala Lumpur, Malaysia
Sanofi-Aventis Administrative Office

Gouda, Netherlands
Sanofi-Aventis Administrative Office

Warsaw, Poland
Sanofi-Aventis Administrative Office

Porto Salvo, Portugal
Sanofi-Aventis Administrative Office

Bucharest, Romania
Sanofi-Aventis Administrative Office

Moscow, Russia
Sanofi-Aventis Administrative Office

Singapore, Singapore
Sanofi-Aventis Administrative Office

Seoul, South Korea
Sanofi-Aventis Administrative Office

Barcelona, Spain
Sanofi-Aventis Administrative Office

Bromma, Sweden
Sanofi-Aventis Administrative Office

Taipei, Taiwan
Sanofi-Aventis Admnistrative Office

Guildford Surrey, United Kingdom
sanofi-aventis Australia & New Zealand administrative office

Macquarie Park, New South Wales, Australia

Conditions

Explore the condition pages connected to this study.

CARCINOMA NON-SMALL-CELL LUNG